Gastrointestinal (GI) cancers, such as colorectal, gastric, and pancreatic cancers, are among the most prevalent and deadly ...
A team at Fortis Memorial Research Institute, Gurugram, removed a 10.3 kg gastrointestinal stromal tumor (GIST) from a ...
Hosted on MSN17d
Repurposed FDA-approved drug could help treat high-grade gliomawhich is already approved by the United States Food and Drug Administration to treat gastrointestinal stromal tumors with a PDGFRA exon 18 mutation as well advanced systemic mastocytosis and ...
Hoth Therapeutics (HOTH) announced breakthrough preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted ...
When Jeffrey Lipow went in for a routine endoscopy, it revealed a serious problem. A follow-up endoscopic ultrasound confirmed he had a tumor under ...
Hoth Therapeutics Inc. has released preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors (GIST).
Hoth Therapeutics announces positive preclinical results for HT-KIT in aggressive cancer gastrointestinal stromal tumours: New York Wednesday, March 19, 2025, 18:00 Hrs [IST] Hoth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback